Riskpilot← Back to searchSign inGet full accessMilliMed AB
ABActiveOrg 5594382144Tortuna Kolsta 5Medical specialists activities · NACE 8622Est. 20235 employees
Revenue 2025
SEK 7,5M
+120% vs 2024
EBITDA margin
25.6%
+7% vs 2024
Equity ratio
40.1%
Financial strength
Net profit 2025
SEK 1,1M
+5% vs 2024
| Revenue | SEK 7,5M | +120% |
| EBITDA | SEK 1,9M | +7% |
| Net profit | SEK 1,1M | +5% |
| Total assets | SEK 3,7M | +65% |
| Equity | SEK 1,5M | +37% |
| Employees | 5 | — |
Legal name
MilliMed AB
Org number
5594382144
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 juni 2023
Share capital
SEK 25 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Deesha, Bashar Salah Polus Deesha, Karam Salah Polus
Company purpose
Konsultverksamhet inom bioteknik och medicin.
Address
Tortuna Kolsta 5
Email
bashardeesha@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 0 | 3 403 | 7 490 |
| Staff expenses | — | −999 | −3 477 |
| EBITDA | — | 1 796 | 1 916 |
| Depreciation & amort. | −0 | −34 | −44 |
| EBIT | 0 | 1 763 | 1 873 |
| Net financials | — | 0 | −0 |
| Profit before tax | 0 | 1 323 | 1 397 |
| Tax | −0 | −274 | −294 |
| Net profit | 0 | 1 049 | 1 103 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 25 | 2 234 | 3 681 |
| Equity | 25 | 1 074 | 1 476 |
| Long-term debt | 0 | — | — |
| Short-term debt | 0 | 720 | 1 291 |
| Total debt | — | 720 | 1 291 |
EBITDA margin
25.6%
This company
15.8%
Market median
+62% vs market
20232025
Equity ratio
40.1%
This company
38.2%
Market median
+5% vs market
20232025
Return on equity
74.7%
This company
18.4%
Market median
+306% vs market
20232025
Net profit margin
14.7%
This company
8.1%
Market median
+81% vs market
20232025
Asset turnover
2.03×
This company
1.12×
Market median
+81% vs market
20232025
Debt / equity
1.49×
This company
0.62×
Market median
-140% vs market
20232025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2026 | |
| Board of Directors | 2023 | |
| Deputy Board Member | 2023 | |
| Board of Directors | 2023 | |
| Former (1) | ||
| Deputy Board Member | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MilliMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karam Salah Polus Deesha | Chairman | 0 companies |
| Dominique Sara Deesha | Deputy Board Member | 0 companies |
| Bashar Salah Polus Deesha | Board of Directors | 0 companies |
| George Maalouf | Deputy Board Member | 0 companies |
| Salah Polus Mikha Deesha | Board of Directors | 0 companies |